688488.SHG Jiangsu Aidea Pharmaceutical Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
12.00 CNY
Close of Nov 5, 2026
11.00 22.55
Market cap
CNY 5.05B
P/E
600.0x
P/B
5.10x
ROE
5.0%
Dividend yield
0.41%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688488.SHG undervalued?

Graham number

The Graham number of Jiangsu Aidea Pharmaceutical Co Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Jiangsu Aidea Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Jiangsu Aidea Pharmaceutical Co Ltd yet.

Jiangsu Aidea Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Jiangsu Aidea Pharmaceutical Co Ltd

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. It offers anti-HIV drugs and human-derived proteins. The company also provides anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was fo…

Full company profile